bioMérieux Balance Sheet

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	569.8	449.8	352.4	552.6	803.5
Cash & Short-Term Investments	569.8	449.8	352.4	552.6	803.5
Cash Growth	26.68%	27.64%	-36.23%	-31.23%	106.45%
Accounts Receivable	766.2	792.3	728.6	740.1	590.6
Other Receivables	244.7	146.4	131.7	116.6	118.3
Receivables	1,011	938.7	860.3	856.7	708.9
Inventory	959.7	1,037	908.5	737.2	620
Prepaid Expenses	-	33	38.6	31.4	23.9
Other Current Assets	-	42.3	45.4	38.8	36.2
Total Current Assets	2,540	2,501	2,205	2,217	2,193
Property, Plant & Equipment	1,657	1,696	1,506	1,370	1,225
Long-Term Investments	129.4	180.2	206	71.2	34.5
Goodwill	727.8	730.4	698.8	812.5	669.5
Other Intangible Assets	401.5	492	528.6	625	411.5
Long-Term Accounts Receivable	10.3	9.1	7.7	12.9	12.6
Long-Term Deferred Tax Assets	108.1	145.9	92.7	58.7	32
Other Long-Term Assets	-	0.1	-	-0.1	0.1
Total Assets	5,575	5,770	5,259	5,187	4,605
Accounts Payable	262.1	272.4	265.1	269.4	239.5
Accrued Expenses	-	451.6	378.7	372.7	318
Short-Term Debt	-	17.7	29	53.9	26.3
Current Portion of Long-Term Debt	131.4	94.4	107	106.9	48.6
Current Portion of Leases	-	29.4	27.4	26.2	24.8
Current Income Taxes Payable	18.3	35.4	52.8	49	67.4
Current Unearned Revenue	-	87.4	80.1	88.5	84
Other Current Liabilities	652.9	146.6	147.2	164.5	147.2
Total Current Liabilities	1,065	1,135	1,087	1,131	955.8
Long-Term Debt	330	206.6	234.2	224.7	265.2
Long-Term Leases	-	142.6	121.2	93.7	97.6
Long-Term Deferred Tax Liabilities	26	25.7	11.1	53	60.3
Other Long-Term Liabilities	48	49.2	53.2	41.2	62.5
Total Liabilities	1,469	1,559	1,507	1,544	1,441
Common Stock	12	12	12	12	12
Additional Paid-In Capital	3,693	3,667	3,420	3,062	2,532
Retained Earnings	397.5	432.2	357.6	452.4	601.1
Treasury Stock	-	-42.9	-19.1	-36	-10.3
Comprehensive Income & Other	-	136.7	-18.5	113.6	-22.7
Total Common Equity	4,102	4,205	3,752	3,604	3,112
Minority Interest	3.9	6.1	-	38.7	51.4
Shareholders' Equity	4,106	4,211	3,752	3,643	3,164
Total Liabilities & Equity	5,575	5,770	5,259	5,187	4,605
Total Debt	461.4	490.7	518.8	505.4	462.5
Net Cash (Debt)	108.4	-40.9	-166.4	47.2	341
Net Cash Growth	-	-	-	-86.16%	-
Net Cash Per Share	0.91	-0.34	-1.40	0.40	2.87
Filing Date Shares Outstanding	117.52	117.93	118.16	117.92	118.25
Total Common Shares Outstanding	117.52	117.92	118.15	118	118.27
Working Capital	1,476	1,366	1,118	1,086	1,237
Book Value Per Share	34.90	35.66	31.76	30.54	26.32
Tangible Book Value	2,973	2,983	2,525	2,167	2,031
Tangible Book Value Per Share	25.30	25.29	21.37	18.36	17.17
Land	-	63.6	58.5	56.5	54.5
Buildings	-	954.2	845.5	823.5	742.7
Machinery	-	808	785.3	682.2	626.4
Construction In Progress	-	355.4	249.6	227.1	157.1

Source: S&P Global Market Intelligence. Standard template. Financial Sources.